ICU Medical Inc: Form 10-Q for the period ended Mar 31, 2012
Filed with the SEC on Apr 20, 2012 and accepted by EDGAR at Apr 19, 2012, 17:37 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2012-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2012-01-01 to 2012-03-31 | $75.5m | us-gaap:Revenues |
| Cost of revenue | 3 months2012-01-01 to 2012-03-31 | $40.5m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months2012-01-01 to 2012-03-31 | $35.0m | us-gaap:GrossProfit |
| Research and development | 3 months2012-01-01 to 2012-03-31 | $2.7m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2012-01-01 to 2012-03-31 | $20.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2012-01-01 to 2012-03-31 | $11.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2012-01-01 to 2012-03-31 | $3.9m | us-gaap:IncomeTaxExpenseBenefit |
| Diluted EPS | 3 months2012-01-01 to 2012-03-31 | $0.53 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2012-01-01 to 2012-03-31 | $0.54 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2012-01-01 to 2012-03-31 | 14,318,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2012-01-01 to 2012-03-31 | $18.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2012-01-01 to 2012-03-31 | $3.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months2012-01-01 to 2012-03-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2012-03-31 | $122.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2012-03-31 | $276.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2012-03-31 | $376.5m | us-gaap:Assets |
| Current liabilities | At period end2012-03-31 | $25.4m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2012-03-31 | $339.9m | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |
| Shares outstanding | At period end2012-04-10 | 14,142,066 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000883984-12-000060. Last ingested by Listed: Nov 14, 2026, 20:54 ET. Listed shows no prices and gives no investment advice.